translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
UNITED STATES: FDA Says Merck's HIV Drug Gets Generic Threat

January 11, 2012
Reuters (01.10.12) - Wednesday, January 11, 2012

The Food and Drug Administration reports it has received applications from drugmakers who wish to produce generic versions of the HIV drugs Isentress (Merck & Co.) and Epivir (GlaxoSmithKline). Isentress was approved for use in adult patients in 2007; in December, FDA expanded its label, allowing the drug to be used in children and adolescents. FDA declined to disclose the names of the generic drug applicants.